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Abstract 
Title: Automated Surveillance of Surgical-Site Infections at a Veteran's Affairs 
Hospital 
Background: Surgical site infections (SSis) account for approximately 17% of 
hospital-acquired infections. These infections result in an increase in emergency 
room visits, outpatient visits, radiology services, home health aide services, and 
readmissions adding an estimated $1 billion-! 0 billion in indirect and direct 
medical costs each year. The CDC and the Surgical Infection Society recommend 
routine surveillance as a method for decreasing the rates of these infections. By 
monitoring SSI rates, areas of improvement can be identified and interventions 
can be made to reduce the incidence of SSis in the hospital. Reductions of up to 
35% have been documented with the implementation of SSI surveillance 
programs. Current methods of surveillance in the VA are only partially 
automated and are labor intensive. Automated methods of surveillance using 
electronic medical records have been proposed to decrease the resources involved 
in SSI monitoring. The VA is well-suited for this with their extensive medical 
records database and relatively closed system of patients. 
Purpose: To construct an automated SSI surveillance system using electronic 
patient medical record data and validate this system by comparing its performance 
to the current surveillance method used at the Durham VA hospital. 
Methods: In this project, we modified the methods previously described by 
Richard Platt to create an automated SSI surveillance system at the VA hospital in 
Durham, North Carolina. We used ICD-9 codes, vital signs, microbiology data, 
consult orders, and pharmacy records sensitive and specific for SSis to identify 
patients with potential infections. Logistic regression was used to create 
predictive models for SSis of different severity. This system was validated by 
comparing its performance to that of the current manual record review performed 
by the infection control department in the hospital on patients who underwent 
surgery at the Durham VA hospital from May 1 '', 2002 to Apri1301h, 2004. All 
surgical-site infections met the criteria set forth by the National Nosocomial 
Infections Surveillance (NNlS) report. The system was evaluated using the 
framework set forth by the CDC Working Group for public health surveillance 
systems 
Results: SSis occurred in 195 of7340 surgeries conducted in the study period 
(2.7% attack rate). Of these, 91 were superficial SSis, 45 were deep SSis, and 59 
were organ/space SSis. Logistic regression models using data found to be 
strongly correlated with SSI diagnoses had a sensitivity and specificity of 90.9% 
and 61.2% for all types ofSSis, 89.2% and 74.2% for severe SSis (deep and 
organ/space) and 89.5% and 74.0% for organ/space SSis, respectively. 
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Conclusions: This study demonstrates that an automated SSI surveillance system 
with reasonable sensitivity and specificity can be created by using data from 
electronic medical records. Such a system can drastically reduce the amount of 
labor necessary for SSI monitoring and increase the speed these complications are 
detected. The information technology used at the Durham VA hospital is similar 
to that used in other VA hospitals, so this system can be exported to other 
hospitals throughout the country. 
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Background 
Surgical site infections (SSis) account for approximately 17% ofhospital-
acquired infections [1]. These infections result in an increase in emergency room 
visits, outpatient visits, radiology services, home health aide services, and 
readmissions [2]. The Centers for Disease Control and Prevention (CDC) 
estimates that approximately 500,000 SSis occur annually in the United States 
with an estimated $1 billion-$1 0 billion in indirect and direct medical costs each 
year [3, 4]. The CDC and the Surgical Infection Society recommend routine 
surveillance as a method for decreasing the rates of these infections. By 
monitoring SSI rates, areas of improvement can be identified and interventions 
can be targeted. Reductions of up to 35% have been documented with the I 
' 
implementation ofSSI surveillance programs [5, 6]. The cost of surveillance has 
been estimated to be only 20% of the cost of treating preventable infections. 
Therefore, creating an efficient and accurate method of SSI surveillance should be 
highly cost-effective [7, 8]. 
As the number of days surgical patients remain in the hospital decreases and the 
proportion of surgeries done on an outpatient basis increases, SSis are more often 
occurring after discharge from the hospital. Between 47% and 84% ofSSis occur 
after discharge from the hospital, and most of these are treated on an outpatient 
basis [2, 9]. Outpatient presentations complicate surveillance of SSis, as patients 
may pursue care outside of the hospital's surveillance system. Routine methods 
3 
to overcome this obstacle such as patient questionnaires have been shown to have 
poor sensitivity (15%-30%) and are also labor intensive [2]. 
Because of the enormous costs and patient morbidity associated with SSis, the 
development of an effective surveillance system is essential. The system needs to 
be sensitive enough to identity SSis occurring both in and out of the hospital in a 
timely manner without requiring increased work for hospital infection control 
teams. The system should also be specific in identifYing infections that meet a 
strict definition of a SSI, such as that proposed by the National Nosocomial 
Infections Surveillance System (NNIS). A baseline rate of infection would be 
established, and the system should be able to pick up differences in SSI rates so 
that proper actions can be undertaken in response to an increase in event rate [10]. 
Current methods of surveillance, such as patient and surgeon questionnaires, are 
time-consuming and often lack the sensitivity, specificity, or timeliness necessary 
to have a significant impact on SSI rates [I 0]. Other methods include the labor-
intensive review of individual full-text patient records. Although risk of SSI for a 
particular patient can be estimated using the Anesthesia Society of America 
(ASA) score, [11, 12] a comprehensive SSI surveillance program should monitor 
all patients regardless of risk score. There is therefore a need for a sensitive 
method of SSI surveillance that is less labor intensive than conventional methods, 
and more timely than methods such as patient questionnaires. 
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Automated methods of surveillance have been proposed to decrease the resources 
involved in SSI monitoring. For example, Richard Platt and colleagues at 
Harvard Pilgrim Healthcare monitored pharmacy dispensing data for certain 
antibiotics, SSI-related ICD-9 codes assigned at discharge, and CPT codes 
specific for wound infection care to identify patients with SSis [10,13]. They 
created an accurate SSI surveillance system to detect SSis in their institution. 
The Veteran's Affairs hospital system has an electronic record system that is 
conducive to the development and enhancement of automated SSI surveillance. 
Patient records including inpatient visits, outpatient visits, pharmacy records, vital 
signs, urgent care visits, and phone calls made to the network are entered and 
retained electronically. As veterans are mostly or fully covered by this medical 
plan, they are likely to seek their inpatient, outpatient, and antibiotic care within 
the network. Also, all veteran's hospitals are linked by a common computer 
system, therefore, patients that travel to different areas of the state or even country 
can potentially be monitored by an effective automated surveillance system. This 
would also allow a system developed at one VA hospital to be used by all VA 
hospitals in the country. Potentially all veterans that undergo surgery at a 
Veteran's Affairs hospital could then be monitored for a SSI. 
Purpose 
In this project, we modified the methods previously described by Platt and others 
to create an automated SSI surveillance system at the VA hospital in Durham, 
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North Carolina. We validated this system by comparing its performance to that of 
the current manual record review performed by the infection control department 
in the hospital on a sample of surgical patients. Successful implementation of this 
system will increase the quality of care received by patients and will decrease 
medical costs by reducing the number of SSI cases in this hospital. This system 
can be implemented in other VA hospitals throughout the country. 
Methods 
Study Population 
The study population consisted of all patients who underwent a surgical procedure 
between May 1 '1, 2002 and April301\ 2004 at the VA medical center in Durham, 
North Carolina (DV AMC). CPT codes for surgical procedures were used to 
identify these patients, as these codes are entered into an electronic database for 
every surgical procedure done in the hospital (see Appendix 1). 
Database management and privacy assurances 
The names and social security numbers of the patients were kept confidential, and 
this data was only used for quality control purposes as a measure of the SSI 
incidence in the hospital. IRB approval was obtained (ID #00877) for this project. 
Case definitions [1] 
Criteria for defining a surgical site infection 
Superficial Incisional SSI 
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Infection occurs within 30 days after the operation and involves only skin or 
subcutaneous tissue of the incision and at least one of the following: 
1. Purulent drainage, with or without laboratory confirmation, from the superficial 
mClSlOn. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from 
the superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat and superficial incision is 
deliberately opened by surgeon, unless site is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending physician. 
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal intimation and discharge confined to the points of 
suture penetration). 
2. Infection of an episiotomy or newborn circumcision site. (relevance) 
3. Infected bum wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see deep 
incisional SSI). 
Note: Specific criteria are used for identifying infected episiotomy and 
circumcision sites and burn wounds. 
Deep Incisional SSI 
Infection occurs within 30 days after the operation if no implantt is left in place 
or within 1 year if implant is in place and the infection appears to be related to the 
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operation and infection involves deep soft tissues (e.g., fascial and muscle layers) 
of the incision and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space 
component ofthe surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon 
when the patient has at least one of the following signs or symptoms: fever 
(>38°C), localized pain, or tenderness, unless site is culture-negative. 
3. An abscess or other evidence of infection involving the deep incision is found 
on direct examination, during reoperation, or by histopathologic or radiologic 
examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician. 
Notes: 
I. An infection that involves both superficial and deep incision sites is recorded as 
deep incisional SSI. 
2. Report an organ/space SSI that drains through the incision as a deep incisional 
SSI. 
Organ/Space SSI 
Infection occurs within 30 days after the operation if no implantt is left in place 
or within I year if implant is in place and the infection appears to be related to the 
operation and infection involves any part ofthe anatomy (e.g., organs or spaces), 
other than the incision, which was opened or manipulated during an operation and 
at least one of the following: 
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1. Purulent drainage from a drain that is placed through a stab woundt into the 
organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue in the 
organ/space. What about blood? 
3. An abscess or other evidence of infection involving the organ/space that is 
found on direct examination, during reoperation, or by histopathologic or 
radiologic examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
t National Nosocomial Infection Surveillance defrnition: a nonhuman-derived implantable foreign 
body (e.g., prosthetic heart valve, nonhuman vascular graft, mechanical heart, or hip prosthesis) 
that is permanently placed in a patient during surgery. 
:j: If the area around a stab wound becomes infected, it is not an SSI. It is considered a skin or soft 
tissue infection, depending on its depth. 
Conventional Identification of SSI 
SSis during the study period were prospectively identified using the partially 
automated surveillance system currently employed at DV AMC by the infection 
control unit. The surgical cohort is established using ICD-9 codes specific for 
surgeries of interest to NNIS (see Appendix 2). SSis are then identified in these 
patients by electronically searching for patients who received an ICD-9 diagnosis 
code of998. Once these patients are identified, their medical records are 
manually reviewed from the electronic medical record database to verify that the 
infections meet the NNIS definitions. In addition, a surgical complications 
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database maintained by another surveillance coordinator for the National Surgical 
Quality Improvement Program (NSQIP) is reviewed by searching the full-text 
medical records of the patients they identified. Ward rosters (SICU, MICU, CCU, 
and Medicine) are also reviewed daily to identify surgical patients in the hospital. 
A full-text review of their medical records is done to identify possible SSis. 
Finally, the infection control team reviews the records of patients identified by 
informal contacts via phone or email about possible SSis. All confirmed SSI 
meet the NNIS criteria. 
Automated SSI Surveillance L 
An electronic filter identified all CPT codes specific to surgical procedures that 
occurred during the study period (see Appendix 2) and entered these patients into 
a separate relational database via a daily file transfer protocol (ftp ). This surgical 
procedure file contained the patient's social security number, CPT surgery code, 
time of surgery, surgical sub-specialty performing the operation, and a text 
description of the type of surgical procedure performed. Additional filters 
running concurrently included all doses and times of administration of inpatient 
antibiotics as well as outpatient prescriptions (Appendix 3), ICD-9 diagnosis code 
associated with a surgical infection (Appendix 4), vital signs (temperature, blood 
pressure, oxygen saturation), microbiology orders and results (Appendix 5), 
abnormal white blood cell counts (> 1 0.0), and consult orders to the hospital 
wound ostomy-continence consult nurse or to physical therapy for wound care. 
The data was limited so that only those items that occurred within 30 days from 
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the time of surgery were used, as this is the criterion used by NNIS for surgical 
infections occurring after most operative procedures. 
Analysis 
The automated system of SSI surveillance was validated by comparing the results 
of the conventional SSI monitoring currently used at DV AMC with that of the 
fully automated system. All analyses were performed in STAT A version 7.0. 
All individual variables (e.g., antibiotics, ICD-9 codes, etc.) were examined for 
their association with a diagnosis of SSI (including individual outcomes of severe 
SSI and organ/space SSI). Two-sided P values were calculated using the Chi 
square test or Fisher's exact test for ordinal and dichotomous variables. 
Continuous variables were compared using 2-sided Wilcoxon rank sum test or the 
Student's t-test. Variables that occurred in fewer than three SSI patients were 
discarded. We then developed composite variables within each data source (e.g., 
inpatient antibiotics, outpatient antibiotics, microbiology orders, microbiology 
results, wound consults, ICD-9 codes, and abnormal vital signs and white blood 
cell counts) using the factors most strongly associated with SSis to maximize the 
sensitivity. The groups used are found in table 1. 
Predictive models were developed including covariates that were associated with 
the outcome with P<O.l on bivariable analysis. Variables were removed in a 
stepwise manner and final associations were recorded as risk ratios (RR) with 
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95% confidence intervals (CI). All covariates were checked for confounding and 
collinearity. If the addition of a confounding variable affected the B-coefficient of 
a covariate by more than I 0% it remained in the model. The groups were also 
analyzed separately in their ability to predict the different types of SSis. The 
probability term in the logistic regression models was adjusted to generate more 
sensitive and more specific models. Receiver operating characteristic (ROC) 
curves were also generated using Stata. 
Evaluation of the system 
The automated SSI surveillance system was evaluated according to the 
recommendations made by the CDC working group for assessing public health 
surveillance systems for early detection of outbreaks [14]. Important 
considerations included timeliness, validity, data quality, representativeness, 
completeness, usefulness, flexibility, acceptability, portability, stability, and cost 
of the system. 
Results 
The Cohort 
The surgical cohort consisted of 7340 procedures in which the conventional 
surveillance program identified 195 SSis. Of these, 59 were organ/space 
infections, 45 were deep SSis, and 91 were superficial SSis. Within the study 
period only two patients had more than one SSI. 
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Bivariable analysis 
Nine groups of variable combinations were found to be strongly associated with 
SSis (table 2). The results of their individual relative risks and 95% confidence 
intervals for their association with SSis are shown in Table 3. ICD-9 coded 
diagnoses related to SSis and antibiotic prescriptions were the strongest predictors 
for detecting any type of infection. 
Predictive models 
An initial predictive model for all SSI was constructed using the composite ICD-9 
codes, antibiotic prescriptions, all microbiology data, vital signs, and wound 
consults (table 2) and had a sensitivity of91% and specificity of61 %. A more 
specific model was also created with this data using logistic regression, with 
resulting sensitivity of 59.9% and specificity of 89.1 %. A receiver operating 
characteristic curve (ROC) was made for this logistic model, with the area under 
the curve calculated to be 0.856 (Figure 2). 
The same nine variables and their components were used to create the best model 
for detecting severe SSis (deep SSis and organ SSis as defined by the NNIS 
criteria). The resulting relative risks for the composite variables are shown in 
Table 4 with 95% confidence intervals. ICD-9 coded diagnoses and antibiotic 
prescriptions remained the strongest predictors of severe SSis. The most sensitive 
model had a sensitivity and specificity of 89.2% and 7 4.2%, respectively and 
included the following variables. A more specific model was also created that 
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had a sensitivity of 58.9% and a specificity of 93.9%. The ROC curve for this 
model is shown in Figure 3, with a calculated area under the curve of0.89. 
Lastly, these same nine composite variables were used to construct a predictive 
model for detecting organ/space SSis. The individual relative risks and 95% 
confidence intervals are found in Table 5. Fewer organ/space SSis were available 
for inclusion, and this reduced the precision of the model. ICD-9 coded diagnoses 
remained the strongest predictors. The most sensitive model had a sensitivity and 
specificity of 89.5% and 74.0%, respectively. A more specific logistic model had 
a sensitivity and specificity of64.9% and 88.7%, respectively. The ROC curve 
for this model had an area under the curve of 0.885 and is found in Figure 4. 
Discussion 
Conventional surveillance of SSis is a time-consuming process, and commonly 
used methods such as patient and surgeon surveys have poor sensitivity. Because 
of the importance of SSis in patient morbidity and medical costs, an effective way 
to monitor these infections would be beneficial. The findings in this study 
demonstrate that such a system can be created with the use of data from an 
electronic patient medical record system. By using pharmacy data, ICD-9 codes, 
patient vital signs and lab values, and microbiology orders and results, a 
surveillance system can be created to detect a substantial number of SSis with 
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reasonable specificity. By focusing on more severe or even organ SSis, one can 
increase the sensitivity and specificity of the system. 
Validity 
This automated surveillance system was evaluated using predictive models for 
different types of SSis. The results of this study show that this automated 
surveillance model is better at detecting more severe SSis. This should be 
expected as patients with more severe infections will have more contact with the 
healthcare system and are more likely to have tests ordered, vital signs recorded, 
and are more likely to receive antibiotics. As many institutions focus on more 
r__ 
severe infections, this is a useful characteristic of this surveillance system. 
However, we did not detect all patients with SSis, regardless of severity. Many 
patients who had surgery at DV AMC were treated for their infections at other 
hospitals within the VA system. The data from all the institutions in North 
Carolina are not yet being received by the surveillance system. Also, procedures 
with implanted prosthetic devices that should be monitored for one year for SSI 
are not currently captured by the current design. As this study monitored patients 
30 days after surgery, the surveillance window used for most operations, those 
patients with SSis who developed infections after this time period would be 
missed. Further study is needed to identify the optimum monitoring window for 
SSis using this system. 
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Although the surveillance system created in this study is much more sensitive 
than common conventional methods such as patient and surgeon surveys, it did 
not match the performance seen in the study done by Richard Platt and others. 
With their data, they could detect up to 92% of SSI with a corresponding 
specificity and positive predictive value of92% and 21% among a population of 
3636 patients that underwent a total of 4086 non-obstetric operations [13]. Using 
only hospital discharge diagnosis codes and pharmacy dispensing data they 
determined a sensitivity and specificity of74% and 98% respectively, with a 
positive predictive value of 48% [13]. There were some fundamental differences 
between their study and this one, however. Ninety-two percent of the patients in 
the Harvard study received care at centers that had automated medical records, 
and those that did not were excluded from the study [2]. Also, an estimated 10% 
of patients in the study did not have prepaid coverage for pharmaceuticals and 
may not have used the Harvard Pilgrim Health Care system for antibiotics [2]. 
This loss of potential data would be avoided in a system that has fully automated 
medical records and a pharmacy plan that assures that patients will obtain their 
antibiotics within reach of the surveillance system. The Platt study also used an 
additional coding system that is unique to Harvard Pilgrim Healthcare. This 
coding system may have helped increase the accuracy of their system. The 
performance of a syndromic surveillance system is dependent on the practices of 
the healthcare workers at the institution. Accurate coding, diagnoses, drug 
prescribing, and test ordering all can increase the performance of a syndromic 
surveillance system. It is possible that their institution has more consistent 
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practices in how they diagnose, treat, and code for SSis. Finally, the frequency of 
the different types of SSis is not mentioned in their results. There may have been 
more severe or organ/space SSis in their study cohort, enhancing the accuracy of 
their system. 
Acceptability 
The acceptability for this type of system is growing rapidly as there is an 
increasing need for earlier disease detection that is less labor intensive than 
conventional methods. Also, electronic patient data is becoming increasingly 
available and most outpatient provider systems now capture pharmacy dispensing 
activity, and claims databases are available to capture information about tests and 
ICD-9 code diagnoses, making the development of a system similar to this easier. 
The model used in this study primarily utilized ICD-9 codes, pharmacy data, and 
microbiology test ordering that should be available at many other institutions. A 
model could then be created similar to this one, tailored to the institution's 
specific drug, testing, and coding utilization as well as the types of infections they 
want to monitor. Such a system requires little maintenance and is much more 
sensitive than surveys and much less labor intensive than full-text patient chart 
review. 
Timeliness 
A particularly powerful advantage that an automated SSI surveillance system has 
over conventional methods is its timeliness. Surgeon and patient questionnaires 
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often take months for receipt and their review necessitates additional labor. Even 
the semi-automated system currently used at DV AMC requires manual patient 
record review and is heavily reliant on ICD-9 codes that can take weeks to be 
entered into the medical record. The automated system uses many sources of 
information, and some data, such as microbiology orders and results, antibiotic 
prescriptions, vital signs, and wound consult orders are available soon after the 
patient seeks medical care. The data is extracted from the core institutional 
database every 24 hours and file transfers can be increased in frequency as 
required. The system's timeliness allows infection control teams to detect SSis 
earlier than conventional methods, expediting interventions to decrease the burden 
of these complications. 
Flexibility and Stability 
Another strength of this system is its flexibility. As there is a sensitivity-
specificity tradeoff when constructing this type of surveillance system, each 
individual institution can tailor their system to complement their current infection 
control program. A surveillance model can be refined to look at specific high-risk 
individuals or surgeries or it can be designed to detect general trends over time by 
increasing the sensitivity. An institution can also decide whether to monitor all 
SSis or focus on more severe cases such as deep and organ/space SSis. This 
system is also a stable one as the definitions for SSis are strictly set forth by NN1S 
and so the outcome measure will not change. Also, as new drugs, tests, and ICD-
9 codes become available, they can easily be added to the predictive model. This 
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flexibility and stability allows a syndromic surveillance system to be created for 
the specific needs of the institution that can change with the advent of new 
technology and antibiotics. 
Cost 
This surveillance system is also a cost-effective way to monitor SSis. The main 
expense of many conventional SSis is the labor involved in manually reviewing 
patient records. This automated method drastically reduces the amount of time 
needed to monitor these infections. Effort is involved in creating the system by 
first collecting the data, organizing it into a relational database, and then creating 
the best predictive model for the types of infections that are to be monitored. The 
created system then needs to be validated before it is implemented. Once in place, 
however, the automated surveillance system requires little maintenance and is 
much less labor intensive than conventional methods. 
Improving the System 
There are many ways to improve this surveillance system. First, the practice of 
the workers within the healthcare system can be altered to conform to a set 
standard for the detection and treatment of SSis. The accuracy of the system is 
directly related to the practices of the healthcare team at the individual institution. 
If drugs, tests, and coding are done haphazardly, the system will be not be able to 
accurately monitor SSis. By encouraging accurate and timely coding, appropriate 
utilization of tests, and proper drug regimens for SSis, the sensitivity, specificity, 
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and positive-predictive value of the surveillance system can be improved. These 
practices will help to increase the efficiency of disease monitoring and of the 
health system as a whole. 
Another way to improve the model would be to look at each surgical specialty 
separately. Physicians treating a SSI after a urologic procedure may treat the 
patient with a different antibiotic than would be used for a SSI occurring after a 
cardiac or gastrointestinal surgery. Identification of the prescribing practices of 
the different surgical specialties would allow a model to be created that is tailored 
to each procedure type. Also, different specialties may vary in their ICD-9 coding 
and test-ordering protocols, and the threshold for obtaining a wound care consult. 
These differences could allow for a unique model to be generated for each 
surgical specialty, creating a more accurate surveillance system. Further study 
needs to be done in this area. 
Quality and Representativeness 
The quality and amount of information available at the time of this study may not 
be representative of that available at other institutions due to the fully electronic 
medical records available in the VA system. Both inpatient and outpatient 
records are contained in this system, and because of their healthcare coverage, the 
vast majority of Veterans who have their surgery at a VA hospital will also 
receive their outpatient care in the VA system. This is particularly important in 
the surveillance of SSis, as a significant percentage of them occur after hospital 
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discharge. It is also noteworthy to mention that the patient population at the VA 
hospital is unique. The current population of Veterans seen at the VA hospital in 
Durham is predominantly male, and their health needs may not represent those 
seen in patient populations at other hospitals. 
Portability and Completeness 
As this study was done in the VA health system it has broad applicability. The 
computer system used in the Durham VA is the same used across the VISN and in 
most Veteran's hospitals in the United States. The surveillance system created in 
this study is therefore portable and can be implemented at other VA hospitals, 
giving them the ability to detect SSis with reasonable sensitivity and specificity. 
Agreements have been reached with infection control chief medical officers and 
information technology at three other major VA hospitals in North Carolina and 
their primary care clinics to expand the developed SSI surveillance system to 
Asheville, Salisbury, and Fayetteville. Approval has also been given by the chief L 
medical officer in VISN 6 to extend the surveillance system to Salem, Richmond, 
Beckley, and Hampton. At this time, many infection control units in VA hospitals 
around the country are under-staffed, and the ability to implement an automated 
system such as this will be a boon. The number of patient records they will need 
to review would be drastically reduced, freeing up their time to do other necessary 
infection control duties. This surveillance method requires little maintenance, 
aside from tailoring it to the specific institution's drug formulary and physician 
practices. Another advantage of the system's portability is that data can be shared 
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among the VA hospitals, and patients who have surgery at one VA hospital and 
are treated for a complication at another can be monitored. This will improve the 
completeness of the data, increase the sensitivity of this surveillance system and 
create a cooperative synergistic relationship between area VA hospitals. 
Conclusions 
In conclusion, this study demonstrates the ability to create a SSI surveillance 
system using patient data from automated medical records. By using ICD-9 
coding, pharmacy records, vital signs, lab data, and microbiology data, a system 
was created that was more sensitive than conventional methods such as patient 
,----
and surgeon surveys. This system is useful because it is not labor intensive, ~ 
requires little maintenance, and is flexible to the needs and practices of an 
individual institution. It also lends itself to an infection control effort to improve 
the coding, testing, and drug dispensing practices at the individual institution, as 
this will increase the sensitivity and specificity ofthe surveillance system. Finally, 
as in this study, an efficient SSI surveillance system created at one institution is 
portable and can then be shared with other institutions using similar electronic 
databases, creating an integrated SSI monitoring system. 
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Appendix 1 
Surgical CPT codes 
Integumentary system 
Musculoskeletal system 
Respiratory system 
Cardiovascular system 
Hemic and lymphatic system 
Mediastinum and diaphragm 
Digestive system 
Urinary system 
Male genital 
Female genital 
Maternity Care and Delivery 
Endocrine system 
Nervous 
Eye and ocular adnexa 
Auditory 
Appendix2 
11400-19499 
20000-29999 
30000-32999 
33010-37209 
38100-38999 
39000-39599 
40490-49999 
50010-53899 
54000-55980 
56405-58999 
59000-59899 
60000-60699 
61000-64999 
64091-68899 
69000-69979 
NNIS Operative Procedure Categories 
Code Operative Procedure 
codes 
AMP Limb amputation 
84.91 
APPY Appendectomy 
47.2, 47.91-47.99 
BILl Bile duct, liver, 
50.4, 
or pancreatic 
surgery 
51.69-51.83, 
51.99, 52.09, 
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Description 
Total or partial amputation 
or disarticulation of the 
upper or lower limbs, 
including digits 
Removal of appendix (not 
incidental to another 
operative procedure) 
Excision ofbile ducts or 
ICD-9-CM 
84.00-84.19, 
47.01-47.09, 
50.0, 50.21-
operative procedures on the 50.61-50.69, 
gallbladder (except cholecystectomy), 51.31-51.63, 
liver, or pancreas 51.89-51.95, 
f 
i 
F 
52.22-52.7, 
52.95, 52.96, 52.99 
CARD Cardiac surgery Open chest procedures on the 35.00-35.95, 
35.98, 35 .. 99 
valves or septum of heart; 
does not include coronary artery 
bypass graft, surgery on vessels, 
heart transplantation, or 
pacemaker implantation 
CBGB Coronary artery Chest procedure to 36.10-36.14, 
36.19 
bypass graft with perform direct 
both chest and revascularization of the heart; 
donor site includes obtaining suitable 
incisions vein from donor site for grafting 
~ 
CBGC Coronary artery Chest procedure to 36.15-36.17, 
36.2 
bypass graft with perform direct vascularization 
chest incision only of the heart using, for example, ~ the internal mammary (thoracic) artery ~ 
I!! 
CHOL Cholecystectomy Removal of gallbladder; includes 51.03, E r 
51.04, 51.21-51.24 
procedures performed using the laparo-
scope 
COLO Colon surgery Incision, resection, or 45.00, 
45.03, 45.41, 45.49, 45.50, 
anastomosis of the large 45.52, 
45.71-45.90, 
bowel; includes large-to-small and 45.92-45.95, 
46.00, 
small-to-large bowel anastomosis 46.03, 
46.04, 46.10-46.14, 
46.43, 
46.52, 46.75, 46.76, 
46.91, 
46.92, 46.94, 48.5-48.69 48.6-48.69 
CRAN Craniotomy mcision through the skull 01.2-01.59, 
02.11-02.14, 
to excise, repair, or 02.91, 
02.92, 
explore the brain; does not 07.51-07.79, 
include taps or punctures 38.01, 
38.11, 38.31, 
38.41, 
38.51, 38.61, 38.81 
24 
CSEC Cesarean section Obstetrical delivery by 74.0-74.2, 
74.4-74.99 
Cesarean section 
FUSN Spinal fusion Spinal fusion and refusion 81.00-81.08, 
81.30-81.39, 
81.62-81.64, 
84.51' 84.52 
FX Open reduction of Open reduction of fracture 79.21, 
79.22, 79.25, 79.26, 
fracture or dislocation oflong 79.31, 
79.32, 
bones that requires internal 79.35, 
79.36, 79.51, 79.52, 
or external fixation; does 79.55, 
79.56 
not include placement of 
joint prosthesis 
GAST Gastric surgery Incision or excision of 43.00, 43.3, 
43.42-43.99, 
stomach; includes subtotal 44.0-44.03, 
44.21, 
or total gastrectomy, 44.29-44.42, 
44.49-44.92 
vagotomy, and pyloroplasty 
HER Herniorrhaphy Repair of inguinal, femoral, 53.00-53.61 
umbilical, or anterior abdominal wall 
hernia; does not include repair of 
diaphragmatic or hiatal hernia or 
hernias at other body sites 
HN Head and neck Major excision or incision of the 30.1-30.4, 
surgery larynx or trachea and 40.40-40.42 
radical neck dissection 
HPRO Hip prosthesis Arthroplasty of hip 81.51-81.53 
HYST Abdominal Removal of uterus through 68.31, 
68.39, 68.4, 68.6 
hysterectomy an abdominal incision 
KPRO Knee prosthesis Arthroplasty of knee 81.54, 
81.55 
LAM Laminectomy Exploration or decompression of 03.01-03.09, 
80.50, 80.51, 
spinal cord through excision or 80.59 
25 
MAST Mastectomy 
85.20-85.23, 
85.50, 
NEPH Nephrectomy 
55.54, 55.91 
PRST Prostatectomy 
SB 
45.51, 
45.91, 
46.02, 
46.39, 
Small bowel surgery 
45.02, 
46.51, 46.71-46.74, 
SKGR Skin graft 
86.60-86.63, 
86.69, 
86.91 
SPLE Splenectomy 
41.95, 41.99 
26 
incision into vertebral structures 
Excision oflesion or tissue 
of breast including radical, 
modified, or quadrant 
resection, lumpectomy, 
incisional biopsy, or 
mammoplasty 
Removal of all or part of 
55.02, 55.11, 55.12, 
the kidney with or without 
removal of related structures 
Suprapubic, retropubic, 
radical, or perineal 
excision of the prostate; 
does not include 
transurethral resection 
of the prostate 
mcision or resection of 
the small intestine; does 
not include small-to-large 
bowel anastomosis 
Full and split-thickness 
21.83, 27.55-27.57, 
skin grafts, including 
flaps, of recipient and 
donor sites 
Complete or partial excision 
41.33,41.41-41.5, 
of spleen 
85.12, 
85.31-85.48, 
85.53-85.7 
55.01, 
55.31-55.52, 
60.3-60.69 
45.01, 
45.31-45.34, 
45.61-45.63, 
46.01, 
46.20-46.31, 
46.41, 
46.93 
08.61, 
85.82-85.85, 
86.65-86.67, 
86.70-86.75, 
41.2, 
41.93, 
-L 
THOR Thoracic surgery N oncardiac, nonvascular 32.3-32.9, 
33.0-33.1, 
chest surgery; includes 33.31-33.49, 
pneumonectomy and 33.98, 
33.99, 34.Dl-34.D3, 
diaphragmatic or hiatal 34.1, 34.3-
34.60, 34.81-34.84, 
hernia repair 34.89, 
34.93-34.99, 
53.80-53.82 
TP Organ transplant Transplantation of human 33.50-33.6, 
heart, kidney, liver, lung, 37.51-37.54, 
41.94, 46.97 
pancreas, or spleen only; 50.51-50.59, 
does not include cornea or 52.80-52.86, 
bone marrow transplants 55.61-55.69 
VHYS Vaginal Removal of the uterus through 68.51-68.59, 
68.7 
hysterectomy vagina or perineal incision ~ [ 
vs Vascular surgery Operative procedures involving 38.00, Iii Ill 
38.02-38.10, f 
arteries or veins; includes aortic 38.12-38.16, 
38.18, 
aneurysm repair, vascular grafts, 38.30, 
38.32-38.40, 
and carotid, iliac, femoral, or 38.42-
38.49, 
popliteal artery operations; does 38.7, 38.80, 
38.82-38.89, 
not include coronary artery bypass 39.0-39.26, 
39.28, 39.29 
grafting 39.50-39.59, 
39.7-39.79 
VSHN Ventricular shunt Extracranial ventricular 02.2, 02.31-
02.39, 
shunts, including revision 02.42, 
02.43 
and removal of shunt 
XLAP Laparotomy Nonspecific exploratory 54.11-54.19, 
54.3-54.59, 
procedures of the 54.71, 
54.72, 54.74, 54.75 
abdominal cavity 
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OBL Other hemic and 
40.3, 
lymphatic systems 
41.98 
OCVS Other cardiovascular 
36.Dl-36.D3, 36.05-
system 
36.31-36.99, 
37.31-37.4, 
37.94-37.99, 
38.52, 38.53, 38.55, 
38.59, 38.60, 
39.94 
OENT Other ear, nose, 
18.21-18.9, 
mouth, pharynx 
20.96-20.99, 21.1, 21.30, 
21.72, 21.82, 
21.89, 
29.0, 
OES Other endocrine system 
06.2-06.99, 
07.21-07.49, 
OEYE Other eye 
08.20-08.59, 
09.20-09.23, 
09.73, 09.81-09.83 
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40.0, 40.21-
40.50-40.9, 
00.50-00.55, 
36.09, 
37.10-37.12, 
37.61-37.91, 
38.50, 
38.57, 
38.62-38.69, 
39.30-39.32, 
39.41-39.49, 
39.8-39.91, 
39.93, 
18.02-18.09, 
20.21-20.23, 
20.41-20.59, 
20.92, 
21.32, 21.4, 
21.84-21.87, 
22.31-22.39, 
26.30-26.32, 
29.2-29.59 
06.01-06.09, 
07.00-07.02, 
07.80-07.99 
08.01-08.09, 
08.62-08.89, 
09.3, 09.6, 
f.--
I 
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OGIT Other digestive system 
42.31-42.32, 
46.42, 46.50, 46.60-46.64, 
46.99, 47.11-47.19, 
48.41-48.49, 
53.7, 
54.61-54.64, 54.73, 
OGU Other genitourinary system 55.53, 55.7-55.89, 
56.40-56.89, 
61.49, 61.92-61.99, 
62.99, 
64.2-64.99, 
65.21-65.89, 
29 
42.01-42.19, 
42.39-42.91, 
46.40, 
46.79-46.82, 
48.0-48.1, 
48.72-48.76, 
53.9-54.0, 
54.92-54.95 
56.0-56.2, 
57.12, 
57.18, 
~ 57.19, 57.21, iii 
57.22, I§ ~ 57.51-57.89, 
58.39, 
58.42-58.5, 
58.91-58.99, 
59.00-59.19, 
59.3-59.71, 
59.79, 
59.91, ~-
59.92, 60.0, 
60.72-60.82, 
60.93, 
61.0, 61.2-
62.0, 62.2-
63.1-63.99, 
65.01-65.09, 
65.92-65.99, 
66.01, 
66.02, 
66.31-66.79, 
66.92-66.94, 
66.97-66.99, 
67.4, 67.51, 
68.29, 68.8-68.9, 
70.4-70.62, 
70.8, 
71.5-71.9 
OMS Other musculoskeletal system 
77.51-77.59,77.60-
79.33, 79.34, 
79.59, 79.80-79.89, 
80.00-80.19, 
80.99, 
81.40-81.49, 
82.99 
83.31-83.93, 
84.48, 84.92-84.99 
ONS Other nervous system 
02.07, 
30 
68.0, 68.2-
69.19-69.49, 
70.72-70.75, 
71.01-71.09, 
76.01-76.09, 
76.2-76.70, 
76.72, 
76.74, 
76.76, 
76.77, 
76.79-76.92, 
76.94, 
76.97, ~ 
77.00-77.39, 
77.99, 
t_ 78.00-78.09, ~· ~ 
78.20-78.79, 
' 
78.90-78.99, 
' 
79.10-79.20, 
79.23, 
79.24, 
79.27-79.30, 
79.37-79.39, 
79.50, 
79.9-79.99, 
80.40-80.49, 
80.6, 80.7-
81.1-81.29, 
81.93-81.97, 
82.01-82.91' 
83.01-83.19, 
84.21-84.40, 
84.44, 
0 1.6, 02.01-
03.4-03.79, 
03.98, 04.01-04.07, 
05.0, 
05.81-05.9, 
31.91 
OOB Other obstetrical procedures 74.3, 75.50, 75.52-75.62, 
OPRO Other joint prosthesis 
ORES Other respiratory system 
31.75-31.79, 
32.29, 33.92-33.93, 
34.85 
OSKN Other integumentary system 
Appendix 3: Antibiotics 
Outpatient antibiotics 
Amoxicillin 
Amoxicillin/clavulanic acid 
Azithromycin 
Ceftriaxone 
Cephalexin 
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Arthroplasty of joints other than 
81.71-81.85 
hip and knee 
02.94-02.99, 
03.1-03.29, 
03.97, 
04.3-04.79, 
05.21-05.29, 
29.92, 
75.93 
81.56-81.61, 
30.01-30.09, 
31.5-31.73, 
32.09-32.22, 
34.71-34.79, 
85.0, 85.24, 
85.25, 
85.86-
85.89, 
85.93-
85.99, 
86.03-
86.09, 86.4, 
86.81-
86.89, 
86.93 
b 
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Ciprofloxacin 
Clarithromycin 
Clindamycin 
Dicloxacillin 
Doxycycline 
Erythromycin 
Fluconazole 
Gentamicin 
Levofloxacin 
Metronidazole 
Linezolid 
Rifampin 
Vancomycin 
Inpatient antibiotics 
Amoxicillin 
Amoxicillin/clavulanic acid 
Ampicillin!sulbactam 
Azithromycin 
Caspofungin 
Cefazolin 
Cefotaxime 
Cefoxitinsodium 
Ceftazidime 
Ceftriaxone 
Cefuroxime 
Cephalexin 
Ciprofloxacin 
Clarithromycin 
Clindamycin 
Doxycycline 
Erythromycin 
Fluconazole 
Gentamicin 
Imipenem/cilastatin 
Levofloxacin 
Linezolid 
Meropenem 
Metronidazole 
Minocycline 
Nafcillin 
Neomycin 
Penicillin 
Piperacillin/tazobactam 
Rifampin 
Timentin 
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Tobramycin 
Vancomycin 
Appendix 4: Diagnoses assigned in hospitals, emergency departments, or 
outpatient settings (ICD9 codes) 
998.0 Postoperative Shock 
998.3 Post-op Wound Disruption 
998.5 Postoperative Infection 
998.51 Infected Post-op Seroma 
998.59 Post-op Infection Nee 
998.83 Non-Healing Surg Wnd 
780.6 Fever 
891.0 Op Wnd Low Leg IS Comp 
891.1 Open Wnd K.nee/Leg-Comp 
682.6 Cellulitis of Leg 
682.9 Cellulitis Nos 
998.9 Surgical Comp Nos 
38.0 Streptococcal Septicemia 
38.1 Staph Septicemia 
38.10 Staph Septicemia Nos 
38.11 Staph Aureus Septicemia 
38.19 Staph Septicemia Nee 
38.2 Pneumococcal Septicemia 
38.3 Anaerobic Septicemia 
38.4 Gram-Neg Septicemia Nee 
38.40 Gram-Neg Septicemia Nos 
38.41 H. injluenzae Septicemia 
38.42 E. coli Septicemia 
38.43 Pseudomonas Septicemia 
38.44 Serratia Septicemia 
38.49 Oth Gram-Neg Septicemia 
38.8 Septicemia Nee 
38.9 Septicemia Nos 
790.7 Bacteremia 
611.0 Inflam Disease of Breast 
682.0 Cellulitis of Face 
682.1 Cellulitis of Neck 
682.2 Cellulitis of Trunk 
682.3 Cellulitis of Arm 
682.4 Cellulitis of Hand 
682.5 Cellulitis of Buttock 
682.6 Cellulitis of Leg 
682.7 Cellulitis of Foot 
682.8 Cellulitis, Site Nee 
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682.9 
686.0 
686.1 
686.8 
686.9 
958.3 
711.00 
996.6 
996.60 
996.61 
996.62 
996.63 
996.64 
996.65 
996.66 
996.67 
996.68 
996.69 
674.3 
879.0 
879.1 
879.2 
879.3 
879.4 
879.5 
879.6 
879.7 
879.8 
879.9 
875.0 
875.1 
Cellulitis Nos 
Pyoderma 
Pyogenic Granuloma 
Local Skin Infection Nee 
Local Skin Infection Nos 
Posttraum Wnd Infect Nee 
Pyogen Arthritis-Unspec 
Infect/Inflam-Dev /Graft 
Infect Due To Device Nos 
Infect D/T Hrt Device 
Infect D/T Vase Device 
Infect D/T Nerv Device 
Infect D/T Urethral Cath 
Infect D/T GU Device Nee 
Infect D/T Joint Prosth 
Infect D/T Orth Dev Nee 
Infect D/T PD Cath 
Infect Due To Device Nee 
Oth Comp OB Surg Wound 
Open Wound of Breast 
Open Wound Breast-Comp 
Opn Wnd Anterior Abdomen 
Opn Wnd Ant Abdomen-Comp 
Opn Wnd Lateral Abdomen 
Opn Wnd Lat Abdomen-Comp 
Open Wound of Trunk Nee 
Open Wnd Trunk Nec-Comp 
Open Wound Site Nos 
Opn Wound Site Nos-Comp 
Open Wound-Chest/S Comp 
Open Wound Chest-Comp 
Appendix 5: Microbiology Orders and Results 
Culture orders 
Abdomen 
Blood 
Bone marrow 
Bronchial wash fluid 
Cerebrospinal fluid 
Feces 
Leg 
Leg-medial surface 
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Nail 
Pelvis 
Peritoneal fluid 
Pharynx 
Pleural fluid 
Scalp 
Skin 
Sputum 
Synovial fluid 
Unknown 
Urethra 
Urine 
Vagina 
Vaginal secretion 
Vein 
Culture results 
Abscess 
Aspirate 
Bone 
Bronchial washes 
Bronchial lavage 
Chest fluids 
Exudates 
Fluid 
Fluid unknown 
Hip fluid 
Hip fluid 
Intravenous catheters 
Peritoneal 
Pleural 
Swab 
Sensorial 
Tissue 
Tracheal aspirates 
Urine-clean-catch 
Urine culture 
Wound 
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Figure 1: Graphical simplification of the identification of potential SSis. Patients found where 
circles overlap are identified as potentially having a SSI. 
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Table 1: Data groups used in multivariable analysis. 
Variable Data Type 
I. SSI-associated diagnoses ICD-9 codes 
2. Outpatient antibiotics Automated pharmacy data 
3. Iopatient anubiotics Automated pharmacy data 
4. All anubiotics Automated pharmacy data 
5. Wound consults Automated consult orders data 
6. Microbiology orders Automated microbiology orders data 
7. Microbiology results Automated microbiology results data 
8. All microbiology data Automated microbiology data 
9. Patient vital signs and labs Automated patient medical records data 
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Table 2: Variables strongly associated with SSis used in multivariable analysis. 
Variable 
39 
I. SSI-associated 
diagnoses 
Description 
682.7, 682.9, 891.0, 891.1, 958.3, 998.59, 
998.83, 998.31,998.32 
Data Type 
ICD-9 codes' 
Area under ROC curve= 0.8560 
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Figure 2: Receiver operating characteristic (ROC) curve for regression model predicting all types 
ofSSis. 
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Table 4: Independent predictors of severe SSis. 
Variable Risk 95% Confidence Sensitivity(%) Specificity(%) 
Ratio interval 
I. SSI-associated 14.47 9.92-21.05 49.0 94.4 
diagnoses 
2. Outpatient antibiotics 4.62 3.15-6.79 52.9 80.9 
3. Inpatient antibiotics 16.54 8.63-31.71 90.2 65.0 
4. All antibiotics 20.79 9.66-44.73 93.1 61.3 
5. Wound consults 7.54 5.11-11.12 39.2 92.6 
6. Microbiology orders 5.91 4.03-8.66 48.0 87.0 
7. Microbiology results 12.50 8.46-18.45 35.3 96.3 
8. All Microbiology data 10.04 6.74-14.95 63.7 85.8 
9. Patient vital signs and 10.22 6.22-16.78 81.4 70.8 
labs 
Area under ROC curve= 0.8902 
1.00 
0.75 
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Figure 3: Receiver operating characteristic (ROC) curve for regression model predicting severe 
types of SSis. 
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Table 5: Independent predictors of organ/space SSis. 
Variable Risk 95% Confidence Sensitivity(%) Specificity(%) 
Ratio interval 
l. SSI-associated 10.17 6.04-17.10 40.4 94.0 
diagnoses 
2. Outpatient antibiotics 3.97 2.37-6.65 49.1 80.7 
3. Inpatient antibiotics 18.70 7.47-46.75 91.2 64.7 
4. All antibiotics 27.58 8.63-88.1 1 94.7 60.9 
5. Wound consults 8.50 5.06-14.28 42.1 92.4 
6. Microbiology orders 7.10 4.24-11.89 52.6 86.5 
7. Microbiology results 10.57 6.12-18.26 31.6 96.0 
8. All Microbiology data 12.38 7.11-21.56 68.4 85.5 
9. Patient vital signs and 9.78 5.08-18.85 80.7 70.5 
labs 
Area under ROC curve = 0.8853 
1.00 
0.75 
i 
=m 
c 
0.50 
Q) 
"' 
0.25 
0.00 
0.00 0.25 0.50 0.75 
1 - Specificity 
Figure 4: Receiver operating characteristic (ROC) curve for regression model predicting 
organ/space types of SS!s. 
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